NewsReplenish NutrAI
Recalls, regulatory actions, lawsuits and new studies on supplements and their ingredients, explained in plain language with links to the original sources.
A UCL study of 201 products and a Which? review of 26 found the same pattern, a wide mix of ingredients with little in common, doses that often don't match the research, and big price differences. Here is what they found and how to read your own label.
Read →
A reorganised FDA office, a planned rule on "generally recognized as safe" ingredients, a debate over what counts as a dietary ingredient, and tougher action on health claims. What is changing in US supplement regulation this year, in plain language.
Read →
The Advancing Menopause Care and Mid-Life Women's Health Act would fund menopause research at the NIH, train more clinicians and run a national awareness campaign. Here is what is in it and where it stands.
Read →
NAFDAC says Menofix Capsules, marketed by PureEve, were never registered, and that some of their reported ingredients have been linked to rare liver problems. What happened, what the research says about liver safety in menopause herbs, and what to check on your own label.
Read →
Today the FDA doesn't have a complete list of the supplements sold in the US. The Dietary Supplement Listing Act, now in both the Senate and the House, would change that. What it would require, why it keeps stalling, and what it would mean for anyone checking a label.
Read →